May-Thurner syndrome (MTS) is a rare cause of deep vein thrombosis. Several cases of MTS because of various causes have been reported. However, MTS due to osteophytes in patients with underlying diffuse idiopathic skeletal hyperostosis (DISH) has not been reported in English literature, to the best of our knowledge. Here, we present the CT findings of MTS in patient with DISH.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407060 | PMC |
| http://dx.doi.org/10.3348/jksr.2022.0132 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
This case report describes a unique presentation of May-Thurner syndrome (MTS) in a 28-year-old woman, characterized by the congenital bifurcation of the left common iliac vein (LCIV) into the outer (OLCIV) and inner (ILCIV) segments. Both veins experienced significant compression - OLCIV proximally and ILCIV medially - due to the overlying right common iliac artery (RCIA) and lumbar spine. The patient presented with bilateral spider veins, lower extremity swelling, pelvic discomfort, and bilateral leg cramping.
View Article and Find Full Text PDFA rare case of May-Thurner syndrome due to external compression of the right and left common iliac veins.
J Vasc Surg Cases Innov Tech
February 2025
Division of Cardiology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA.
May-Thurner syndrome, also known as external iliac compression syndrome, is a rare but commonly underdiagnosed cause of asymmetric lower extremity edema. Here we describe a case of May-Thurner syndrome owing to external compression of the right and left common iliac veins presenting as chronic worsening asymmetric right greater than left lower extremity edema. Initial etiology workup was unremarkable, and further diagnostics revealed compression of the right common iliac vein at the bifurcation of the right common iliac artery between the right external and internal iliac arteries with concomitant compression of the left common iliac vein.
View Article and Find Full Text PDFMay-Thurner Syndrome Causing Unilateral Varicocele Treated With Endovascular Embolization.
Cureus
November 2024
Internal Medicine, Dr. Sulaiman Al Habib Medical Group, Buraidah, SAU.
May-Thurner syndrome is a rare disorder characterized by the right common iliac artery overlies and compresses the left common iliac vein against the lumbar spine with or without iliofemoral deep venous thrombosis (DVT). The majority of cases are female and have been associated with the development of vulvar varicosities, particularly during pregnancy. Interestingly and very rarely, this condition has also been identified as a potential cause of varicoceles in males.
View Article and Find Full Text PDFSafety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study.
Blood Adv
December 2024
Charité, University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany.
Article Synopsis
- Glofitamab, a bispecific antibody targeting CD20 and CD3, shows promise for treating relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) in heavily pretreated patients, with an overall response rate of 47%.
- In a study involving 70 patients in Germany, Austria, and Switzerland, the median number of prior treatments was four, with notable safety concerns including cytokine release syndrome in 40% of cases.
- Important findings indicate that elevated LDH levels predict poorer outcomes, and recent treatment with bendamustine may reduce the efficacy of glofitamab, suggesting careful treatment sequencing is essential.
A single center retrospective study on real world CAR T-cell therapy: focus on early hematological toxicity.
Front Med (Lausanne)
November 2024
Department of Hematology and Oncology, Saarland University Hospital, Homburg, Germany.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and multiple myeloma have poor outcomes. CAR-T completely changed the landscape of therapy options, improving not only response rates but also survival outcomes. Hematological toxicity after chimeric antigen receptor therapy (CAR-T) is of increasing interest, being a recognized prognostic factor in this setting.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!